Idle Your Engines: Feds Instruct Agencies to Stand Down on "Fair Pay and Safe Workplaces"
Client Alert | 1 min read | 10.26.16
On October 25, OFPP issued a Memorandum for Chief Acquisition Officers instructing agencies to refrain from implementing the “Fair Pay and Safe Workplaces” final rule (which was enjoined by a federal court on October 25, as discussed here) and ensure that “new solicitations do not include representations or clauses that the enjoined coverage of the rule would have required” and that, “[i]f a solicitation has been issued with [the] representations or clauses …, amend those solicitations immediately to remove” them. The memorandum also states that GSA has “halted actions to release the changes for the System for Award Management (SAM) that would support bidder and contractor submission of information on labor law violation decisions” and those that “would support public disclosure of this information in the Federal Awardee Performance and Integrity Information System (FAPIIS).”
Insights
Client Alert | 2 min read | 05.09.25
FDA Seeks Stakeholder Consultation on Prescription Drug User Fee Reauthorization
On May 8, the U.S. Food and Drug Administration (FDA) took steps to begin the process for reauthorizing the Prescription Drug User Fee Amendments (PDUFA) by announcing a public meeting to be held on July 14, 2025. The agency invited public stakeholders, including patient and consumer advocate groups, health care professionals, and scientific and academic experts to participate in the meeting and subsequent public meetings to consult on the PDUFA reauthorization.
Client Alert | 2 min read | 05.09.25
New SF-328 for Foreign Ownership, Control, and Influence Assessments Approved, Publication Imminent
Client Alert | 4 min read | 05.08.25
Client Alert | 4 min read | 05.07.25
